This milestone reflects the continued confidence of our existing investors—not only in our progress to date, but in the long-term vision we are building together.
The additional capital will support FIZE’s continued expansion across the United States, Europe, and Japan, as well as the deepening of clinical collaborations with leading healthcare institutions. It will also accelerate the development of the next generation of data-driven, AI-enabled fluid management solutions.
At FIZE, we believe fluid management should not be reactive. By transforming continuous urine output into a meaningful and actionable clinical signal, we aim to enable earlier intervention and support improved outcomes for critically ill patients.
https://www.benzinga.com/pressreleases/26/03/n51537389/fize-medical-announces-6-million-warrant-exercise-bringing-total-series-a-financing-to-36-million
